Bizily Scott

Chief Legal Officer

Bizily Scott has filed 10 SEC Form 4 filings (21 transaction rows) across 1 company, with disclosures dating back to 2025. 10 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.

On the most recent filing, Bizily Scott is listed as Chief Legal Officer at 4D Molecular Therapeutics, Inc. Inside the rolling window, Bizily Scott reported no open-market purchases and 11 open-market sales totaling $385K in FDMT. The largest disclosed transaction in the window is a sale of 9,810 FDMT shares on Jun 23, 2026, worth $118K.

Companies traded

Other insiders at FDMT

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$385K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
FDMTSale$8KSep 3SEC ↗
FDMTSale$20KAug 17SEC ↗
FDMTSale$20KAug 17SEC ↗
FDMTSale$92KJul 2SEC ↗
FDMTSale$118KJun 25SEC ↗
FDMTSale$18KDec 19SEC ↗
FDMTSale$17KNov 19SEC ↗
FDMTSale$32KOct 27SEC ↗
FDMTSale$17KOct 20SEC ↗
FDMTSale$24KOct 14SEC ↗
FDMTSale$19KSep 26SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Bizily Scott made?

Bizily Scott has filed 10 SEC Form 4 filings (21 transaction rows) across 1 company since 2025.

Which companies does Bizily Scott trade?

Bizily Scott has filed SEC Form 4 disclosures for 1 company, including FDMT.

When was Bizily Scott's most recent SEC Form 4 filing?

Bizily Scott's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.

What is Bizily Scott's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Bizily Scott is listed as Chief Legal Officer.

What is Bizily Scott's total buy and sell value in the current window?

Inside the rolling retention window, Bizily Scott bought $0 and sold $385K based on SEC Form 4 filings.

What was Bizily Scott's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 9,810 FDMT shares on 2026-06-23, worth $118K, per SEC Form 4 filings.